LTR Pharma’s pivotal trial for its novel intranasal formulation SPONTAN demonstrates it outperforms traditional oral erectile ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on Royalty Pharma (RPRX – Research Report), with a ...

Shares of Upstream Bio opened 26.5% above the initial public offering price in their Nasdaq debut on Friday, valuing the drug developer at $1.05 billion.

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

We expect the company to post revenue of $22.2 billion and earnings of $2.20 per share, broadly aligning with the consensus ...

ANI Pharmaceuticals acquired Alimera Sciences, boosting its rare disease segment with a couple of durable ophthalmology ...

Chemists have developed a new chemical reaction that will allow researchers to synthesize selectively the left-handed or right-handed versions of 'mirror molecules' found in nature and assess them for ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...

Biogen plans to start a Phase III trial for felzartamab as a treatment for antibody-mediated rejection, and two other ...

Argentina’s Foreign Minister, Diana Mondino, concluded her five-day official visit to India during which she co-chaired the 7th India-Argentina Joint Commission Meeting (JCM) alongside External ...